Report: Combination therapy more effective for diabetics

03/25/2008 | Reuters

A report shows that a combination of simvastatin and fenofibrate works better than either drug alone at normalizing lipid levels in Type 2 diabetes patients who do not have coronary heart disease. "Aggressive treatment of this mixed dyslipidemia may be very important in saving the lives of our diabetic patients," a researcher said.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC